Cellceutix Corporation Selects Destum Partners to Partner Psoriasis Compound - SYS-CON Media (press release) (blog)

Cellceutix Corporation Selects Destum Partners to Partner Psoriasis Compound SYS-CON Media (press release) (blog) Additionally, studies show that between 10 and 30 percent of people with psoriasis also develop psoriatic arthritis. Psoriasis greatly affects the quality ... and more »

Arthritis drugs get PBS listing - Pharmacy News

Arthritis drugs get PBS listing Pharmacy News Simponi will be PBS listed on the PBS for three rheumatology conditions - rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. ... and more »

Adalimumab Works in Refractory Psoriatic Arthritis - MedPage Today

Adalimumab Works in Refractory Psoriatic Arthritis MedPage Today Treatment with adalimumab (Humira) was effective for both joint and skin manifestations of psoriatic arthritis in patients whose disease had not responded ...

Phase II Study of CH-4051 in Rheumatoid Arthritis - Drug Discovery & Development

Phase II Study of CH-4051 in Rheumatoid Arthritis Drug Discovery & Development Diseases that may potentially be treated with these compounds include rheumatoid arthritis, psoriasis, Crohn's disease, ankylosing spondylitis, uveitis, ...